PharmaLytica 2024 to draw 200+ exhibitors
News

PharmaLytica 2024 to draw 200+ exhibitors

10th edition of the event is scheduled to be held during May 30-June 1 at Hitex, Hyderabad

  • By IPP Bureau | April 19, 2024

PharmaLytica Expo, the flagship event within South India's pharmaceutical industry, is eagerly approaching its milestone 10th edition, scheduled from May 30 - June 1, 2024, at HITEX, Hyderabad a prominent pharmaceutical hub in India.

Organised by Informa Markets in India, this event marks a decade of excellence, providing a vital business platform for showcasing the latest industry trends, innovations, and business opportunities across Pharma Machinery & Packaging, Lab Analytical & Cleanroom, and Pharma Ingredients segments.

In its upcoming 10th edition, PharmaLytica 2024 anticipates the participation of more than 200 exhibitors and brands from across the country, including major industry players such as Schneider Electric, Integrated Cleanroom Technology, Nicomac Taikisha Clean Rooms, HLE Glascoat Ltd, Scientific Research Instruments Company, Ami Polymer & many more. Furthermore, the event enjoys robust support from esteemed associations like BDMAI, FOPE and Telangana Life Sciences.

Speaking on the announcement of PharmaLytica 2024, Yogesh Mudras, Managing Director, Informa Markets India said, “We are delighted to embarked upon the decade long exciting journey of PharmaLytica, a path that has been dynamic, exciting, and nurtured the direction of the industry. As we scale up with passion and conviction, we recognize the pivotal role of this platform in nurturing industry direction.

Noteworthy initiatives like the National Policy on Research and Development and Innovation in Pharma-MedTech Sector and the Ayushman Bharat programme are poised to enhance research capabilities and expand healthcare access. The substantial increase in governmental spending on pharmaceuticals, reaching Rs 90,658.63 crores in the interim Budget this year, an increase of 12.6 percent over the previous and the allocation of Rs. 1,000 crore for promoting bulk drug parks in FY25, underscores a commendable commitment to this cause. With a target of reaching US$450 billion by 2047, the industry will potentially fuel economic growth and employment opportunities, leveraging digital technologies such as data analytics and AI/ML to revolutionize R&D processes.

Under the vital umbrella of expos such as PharmaLytica, ideas flourish and businesses thrive, driving progress within the pharmaceutical landscape,” he added.

Upcoming E-conference

Other Related stories

Startup

Digitization